167 companies

Bonraybio

Market Cap: NT$2.8b

A development stage company, manufactures medical instruments and solutions for the male infertility market.

6955

NT$114.00

7D

-5.4%

1Y

-30.3%

Bayer (Peru)

Market Cap: S/294.5m

Engages in the pharmaceuticals, consumer health, and crop science businesses in Peru.

BAYERI1

S/20.00

7D

0%

1Y

41.8%

Jeil Pharma Holdings

Market Cap: ₩97.9b

Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.

A002620

₩6,380.00

7D

-2.7%

1Y

-31.3%

Pangaea Oncology

Market Cap: €56.4m

A medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

PANG

€1.57

7D

4.0%

1Y

-5.4%

hVIVO

Market Cap: UK£47.1m

Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.

HVO

UK£0.069

7D

-3.5%

1Y

-31.5%

Immuno-Biological Laboratories

Market Cap: JP¥9.3b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

4570

JP¥994.00

7D

-0.4%

1Y

100.0%

Chi Sheng Pharma & Biotech

Market Cap: NT$1.8b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

4111

NT$30.25

7D

-1.6%

1Y

0.8%

Synbio Tech

Market Cap: NT$1.8b

Manufactures and sells human healthcare products and probiotics for animals.

1295

NT$51.30

7D

4.1%

1Y

-59.6%

Avecho Biotechnology

Market Cap: AU$78.5m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India.

AVE

AU$0.021

7D

-10.9%

1Y

310.0%

CCME Global

Market Cap: ₹5.2b

Does not have significant operations.

514336

₹114.95

7D

-3.2%

1Y

391.4%

Haleos Labs

Market Cap: ₹4.8b

Engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.

HALEOSLABS

₹1,587.30

7D

-2.0%

1Y

38.1%

Wai Yuen Tong Medicine Holdings

Market Cap: HK$378.9m

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.

897

HK$0.34

7D

25.9%

1Y

11.5%

BIO-FD&CLtd

Market Cap: ₩70.1b

Develops active ingredients for anti-aging cosmetics in South Korea.

A251120

₩8,060.00

7D

-5.8%

1Y

-58.2%

WDB coco

Market Cap: JP¥6.2b

Provides contract and human resource services to pharmaceutical companies in Japan.

7079

JP¥2,563.00

7D

-0.3%

1Y

-12.6%

Winston Medical Supply

Market Cap: NT$1.1b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

New

6817

NT$60.20

7D

0%

1Y

-46.3%

Prince Pharmaceutical

Market Cap: NT$1.1b

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.

6935

NT$30.25

7D

0%

1Y

14.2%

P&K Skin Research Center

Market Cap: ₩49.6b

Engages in the evaluation and research of dermatological products in South Korea.

A347740

₩1,718.00

7D

-3.1%

1Y

-45.1%

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

BIOQ

US$32.50

7D

0%

1Y

-24.8%

Pharma-Bio Serv

Market Cap: US$12.9m

Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

PBSV

US$0.56

7D

0%

1Y

-5.8%

Par Drugs and Chemicals

Market Cap: ₹1.1b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.

PAR

₹91.68

7D

1.3%

1Y

-3.2%

Vineet Laboratories

Market Cap: ₹649.0m

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India.

VINEETLAB

₹33.79

7D

-0.09%

1Y

5.7%

Phong Phu Pharmaceutical

Market Cap: ₫158.4b

Engages in the production, sale, and distribution of medicines primarily in Vietnam.

New

PPP

₫18,000.00

7D

0%

1Y

-11.8%

Double Bond Pharmaceutical International

Market Cap: SEK 12.9m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.

DBP B

SEK 0.12

7D

9.1%

1Y

-72.7%

Page 5 of 5